CSIMarket
 
Enfusion inc   (ENFN)
Other Ticker:  
 
    Sector  Technology    Industry Software & Programming
   Industry Software & Programming
   Sector  Technology
 
Price: $9.0900 $-0.21 -2.258%
Day's High: $9.37 Week Perf: -2.88 %
Day's Low: $ 9.04 30 Day Perf: 1.68 %
Volume (M): 563 52 Wk High: $ 11.56
Volume (M$): $ 5,119 52 Wk Avg: $9.17
Open: $9.34 52 Wk Low: $7.37



 Market Capitalization (Millions $) 782
 Shares Outstanding (Millions) 86
 Employees 892
 Revenues (TTM) (Millions $) 174
 Net Income (TTM) (Millions $) 9
 Cash Flow (TTM) (Millions $) -27
 Capital Exp. (TTM) (Millions $) 7

Enfusion Inc
Enfusion is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Our solutions products and services are designed to remove technological and information barriers, allowing investment managers to confidently make and execute better-informed investment decisions in real time. By unifying mission-critical systems and coalescing data into a single dataset, we simplify investment and operational workflows, resulting in a single source of truth. This enables stakeholders across the client organization to interact with one another more effectively throughout the investment management lifecycle.
We believe, by means of our purposefully-designed, interconnected systems underpinned by one dataset, we are the only solution that allows clients to see and interact with all parts of the investment management lifecycle, ranging from portfolio construction, trading, risk management, accounting and operations through to investor reporting, seamlessly in real time, in one screen, in one solution. As a result, our solution enables clients to better align teams, optimizing their investment decision-making, operations and technology footprint and lowering operating costs. By harnessing the efficiencies, agility and scale inherent to our cloud-native, multi-tenant software that is integrated with a suite of technology-powered, managed services, we believe we have created the industry's most compelling investment management solution, capable of shaping and addressing the evolving demands of the global investment management landscape.
Our cloud-native, purpose-built, end-to-end solution enables our clients to easily access and analyze investment data in real time, perform complex calculations quickly, and interact with markets electronically, resulting in better, more informed investment decisions and actions. Our solution can be tailored to specific work streams, client segments, and asset classes. Rather than requiring large, specialized workforces for local or tenant-by-tenant deployments, changes to our solution are made remotely within a single code base, with no client intervention or interaction. Individual, sponsoring client software enhancements are made available to all clients at the same time. This process, in which our client community continuously contributes to the ever-evolving nature of our solution, increases the value of the solution to all of our clients.
Our solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, driving better insights into and control over the business activities of the investment manager and investment operations. We recognize that, despite increasing market pressures to the contrary, some clients may not be in a position to replace all of their systems at once. Therefore, we have designed our solution to allow our clients to use some or all of our solution to manage their investment lifecycle workflow and also to augment or integrate into their existing workflows or systems, giving them the flexibility to expand their usage and us the ability to solve their unique needs through time.
Portfolio Management System, or PMS: Able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record, or IBOR, for CIOs and portfolio managers, features a full suite of valuation and risk tools and allows users to analyze aggregated or decomposed portfolio data by any number of customizable dimensions.
Order and Execution Management System, or OEMS: Intertwined with our PMS, this module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders for a variety of asset classes and with a choice of hundreds of executing counterparties globally, manage trade orders and systemically enforce trading regulations and internal guidelines.
Accounting/General Ledger System: Underpinning our PMS and OEMS systems, our accounting system features a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions directly from our PMS'providing CFOs, COOs, accountants and operations teams a complete, real-time accounting book of record, or ABOR.
Enfusion Analytics System: Connected in real time with our PMS and OEMS, Enfusion Analytics system enables CIOs, portfolio managers, traders and analysts to utilize the solution's comprehensive client data insights to analyze portfolios through time horizons and automate customized visualized reports for both internal and external stakeholders. This module also acts as a centralized data warehouse that may be accessed or utilized by both individual and systematic users.
Technology-Powered, Managed Services: We offer access to technology-powered, managed services designed to maximize the power of the Enfusion solution. By using expert teams empowered by technology to address time-consuming front-, middle- and back-office administrative tasks related to the investment lifecycle such as performing various fund and position level reconciliations, processing corporate actions, proactive trade break resolutions, and back up accounting against fund administrators, our clients are able to focus on their highest-value business activities and recognize the full benefit of our solution.


   Company Address: 125 South Clark Street Chicago 60603 IL
   Company Phone Number: 253-9800   Stock Exchange / Ticker: NYSE ENFN
   


Customers Net Income fell by ENFN's Customers Net Profit Margin fell to

-47.67 %

9.53 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Enfusion Inc

Enfusion Inc. Celebrates Impressive EPS Surge in Q4 2023 Financial Report

Enfusion Inc, a leading SaaS platform for investment managers, has announced its financial results for the fourth quarter of 2023. The company reported a significant increase in earnings per share (EPS), with it soaring to $0.01 per share. Alongside this, there was a boost in revenue of 14.915% to $46.56 million, compared to the same period the previous year.
Enfusion Inc outperformed many of its contemporaries in the Software & Programming sector in terms of business growth. While most entities in the industry experienced a 3.78% advance in business from the previous year, Enfusion Inc's growth was even higher.

Management Changes

Enfusion Elevates Valeria Gutowski to Chief Accounting Officer, Focusing on Stronger Financial Reporting and Compliance in Pursuit of Market Success

Published Thu, Jan 18 2024 1:15 PM UTC


Ms. Gutowski, who will assume her new position on January 15, 2024, brings a wealth of experience and expertise to her role. As Chief Accounting Officer, she will be responsible for ensuring the accuracy and timeliness of Enfusion's financial reporting, overseeing compliance with SOX 404 requirements, managing tax-related matters, and fostering the development and imple...

Enfusion Inc

Enfusion Inc (ENFN) Experiences Slowdown in Revenue Growth, Raising Concerns Over Future Performance

Enfusion Inc (ENFN) recently released its financial results for the July to September 30, 2023 period, which have left some analysts concerned about the company's overall performance and future prospects. While net profit per share remained unchanged at $0.02 compared to the previous year, and earnings per share increased by a significant 100% from the prior quarter, there are several factors that indicate a potentially bearish outlook for the company.
Firstly, revenue for the quarter increased by 12.002% to $43.85 million from $39.15 million in the same quarter a year ago. However, this sequential rise of 3.145% from $42.51 million suggests a slowdown in revenue growth. Some analysts attribute this deceleration in revenue growth to a potential decrease in demand for Enfusion Inc's products and services. This concern is further reinforced by the fact that the level of accounts receivable has declined to $24.9 million, which can be interpreted as a sign of slowing demand.

Enfusion Inc

Enfusion Inc Crushes Expectations with Remarkable Second Quarter Earnings in 2023

Enfusion Inc is a software and programming company that operates in the finance and investment industry. The company recently released its financial results for the second quarter of 2023, showing positive profitability and revenue growth compared to the previous year.
During the second quarter of 2023, Enfusion Inc's profitability turned positive, with earnings of $0.01 per share. This is an improvement from a loss of $0.03 per share in the same quarter of the previous year. However, earnings per share dropped by 75% from $0.04 per share in the previous reporting season. Despite this drop, the company still managed to achieve a positive profitability.

Enfusion Inc

Enfusion Inc Achieves Extraordinary Financial Milestones with Remarkable Revenue Growth and Profitability

Enfusion Inc is a leading provider of technology solutions and managed services for the investment management industry. The company has been around since 2006 and has grown exponentially ever since. The most recent financial results for the company have been nothing short of astounding, as the company has turned profitable in a span of a year.
Due to astonishing revenue elevation, the company turned into profitability. The revenue rose by an impressive 20.005% to $40.97 million, and the earnings per share were at $0.04, in contrast to $-0.10 in the same span a year before. The sequential increase in revenue by 1.121% from $40.52 million is also noteworthy. These financial achievements are largely due to the company's continued focus on spending to improve progress prospects, while reacting with marketing to overcome the influence of expense woes helped by the labor supply-demand imbalance.






 

Enfusion Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Enfusion Inc does not provide revenue guidance.

Earnings Outlook
Enfusion inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com